Speakers & Presenters

All Speakers

Filter by letter

CEO/PRESIDENT/PRINCIPAL/FOUNDER, PROTRANSIT NANOTHERAPY LLC

ProTransit Nanotherapy, Inc.

Omaha, Nebraska, United States

Chris Mancill

SENIOR VICE PRESIDENT & HEAD WORLDWIDE VALUE ACCESS & PAYMENT AND HEALTH ECONOMICS AND OUTCOMES RESEARCH, BRISTOL MYERS SQUIBB COMPANY

Policy Outlook: Understanding the Effects of the U.S. Inflation Reduction Act

New York, New York, United States

Dan Mandell, PhD

CO-FOUNDER AND CEO, GRO BIOSCIENCES

GRO Biosciences

Applying Advances in Synthetic Biology to Drug Discovery

Cambridge, Massachusetts, United States

William Mann, PhD

PRESIDENT & CEO, ARCHIMMUNE THERAPEUTICS, INC.

Archimmune Therapeutics, Inc.

Lexington, Massachusetts, United States

Tyler Martin

CHAIRMAN & CEO, AEOLIAN BIOTECH

Aeolian Biotech

Roca, Nebraska, United States

David Mazzo, PhD

CHIEF EXECUTIVE OFFICER , LISATA THERAPEUTICS, INC.

Lisata Therapeutics, Inc.

Basking Ridge, New Jersey, United States

Charlie McDermott, MBA

CHAIRMAN AND CEO, PRIMMUNE THERAPEUTICS

Primmune Therapeutics, Inc.

Carlsbad, California, United States

Scott Megaffin

CEO, ADISO THERAPEUTICS

adiso therapeutics

Concord, Massachusetts, United States

Glennis Mehra

DIRECTOR, BIOLABS NEW YORK

Building a Resilient Biotech Company: Management Lessons Through Capital Downturns

New York, New York, United States

Chris Min, MD, PhD

CEO, LONGEVERON LLC

Longeveron Inc.

Miami, Florida, United States

James G. Moe Moe, MD, PhD

PRESIDENT, OLIGOMERIX, INC.

Oligomerix, Inc

White Plains, New York, United States

Mani Mohindru , PhD

CHIEF EXECUTIVE OFFICER, NOVASENTA

Novasenta

Pittsburgh, Pennsylvania, United States

Daphna Mokady, PhD

CSO, ENDOGENA THERAPEUTICS

Endogena Therapeutics

Pierre Montanaro, Bcom

PRESIDENT & CEO, DEVONIAN HEALTH GROUP INC.

Devonian Health Group Inc.

Montmagny, Quebec, Canada

Jill M. Mooney

SVP, RESEARCH AND DEVELOPMENT, ELEVATEBIO

Applying Advances in Synthetic Biology to Drug Discovery

Jeff Morell

ASSOCIATE PARTNER , MCKINSEY & COMPANY

Applying Advances in Synthetic Biology to Drug Discovery

John Murphy

CHIEF POLICY OFFICER, BIOTECHNOLOGY INNOVATION ORGANIZATION

Policy Outlook: Understanding the Effects of the U.S. Inflation Reduction Act

Washington, United States

Karthik Musunuri

CEO, AVSTERA THERAPEUTICS CORP.

Avstera Therapeutics Corp.

Philadelphia, Pennsylvania, United States

Shankar Musunuri, MBA, PhD

CHAIRMAN AND CHIEF EXECUTIVE OFFICER, OCUGEN

Ocugen, Inc.

Malvern, Pennsylvania, United States